Categories
Health

Summer time Drink Recipes – The New York Occasions

Like moving turtleneck sweaters to the back of the closet, it’s time to retire well-aged whiskeys and bring on the clear spirits, fruit juices and crushed ice. The warmer seasons demand refreshing drinks, alcoholic or not, served in tall, frosted glasses.

The classic repertoire has much to offer in this category; it’s hard to go wrong with a gin and tonic or a caipirinha. But many of these summer staples could stand a creative update or a touch of surprise without compromising their honest appeal. Detailed below are a gin and tonic with a Spanish twist, sangria made with rosé wine and a Bellini buzzed with one of the new pink Proseccos that did not exist when Giuseppe Cipriani created the now-classic in Venice. There is also a slushy Southside, with rum replacing the usual gin, a Paloma bolstered with grapefruit liqueur and spiked with chile, and a spritzer bejeweled with cherries, which always ramp up the refreshment level of a glass of wine, especially red.

For drinks of the nonalcoholic sort, Agua Fresca is the Mexican and Central American quencher made by simply adding some fruit purée or juice to cold water with a squirt of lime and, depending on the ripeness of your fruit, a touch of sweetener. Almost anything goes for this drink, even non-sweet additions like cucumbers. The Fourth of July American version would be lemonade, an almost blank canvas that can be splashed with summery flavors like strawberry, peach or mango.

Beyond these suggestions, you can add liqueurs like triple sec and elderflower or white rum to make a happy-hour iced tea, or drop a jigger of Sambuca into iced coffee to serve with or instead of dessert. Gin in the lemonade is a quick nod to Tom Collins, a summer standby, and crushed fresh berries enliven chilled sparkling cider, alcoholic or not.

Having fresh fruit, like watermelon and strawberries, on hand will give you access to festive, colorful summer drinks on a moment’s notice. Process some of it, diced, in a blender, stir into a glass of ice with (or without) the spirit of your choice and top it off with soda water. You might consider expanding your wardrobe of fruit liqueurs and spirits beyond the usual orange to include grapefruit, lemon, raspberry and apricot. In small amounts they can brighten up many summer drinks. And for sweetening drinks, especially chilled ones, it’s a good idea to have simple syrup on hand, made by simmering equal parts granulated sugar and water together until the sugar dissolves and the mixture is clear. Refrigerated, the syrup will keep for a month.

To serve, warm-weather drinks demand generous glasses; tall ones are best, chilled before filling. Plastic is often the choice for outdoors, and manufacturers have improved the quality of these, though glass has more class. And then there’s the question of straws. Avoid plastic; look for paper in the disposable department, or some of the new, reusable stainless-steel ones. There are also silver straws, long, and often with a spoon at the end for a posh yet convenient touch.

For drinks to serve more than two (or to have refills ready and to transport outdoors), you’ll want a pitcher; some have lids or come fitted with an enclosed receptacle for ice. A long mixing spoon is a useful accessory, and a good citrus juicer is also a worthwhile investment. Frozen drinks also call for a blender to reduce the ice to slush or fruit into purée; there are compact cordless ones on the market that can even go to the beach or on a picnic. And be sure your ice maker or ice cube trays are ready for overtime.

Adapted from Rosie Schaap

Time: 15 minutes plus chilling

Yield: 6 servings

1 ½ cups mixed red and pink fruit, such as raspberries, halved strawberries and grapes, pitted cherries, cubed apple with red or pink skin, peeled pink grapefruit or blood orange segments

1 tablespoon granulated sugar

¼ cup triple sec or other orange liqueur

1 bottle (750 ml) chilled rosé wine

½ cup chilled pomegranate juice

1. Place the fruit, sugar and triple sec in a pitcher and stir to combine. Refrigerate until the fruit softens a bit (at least 4 hours and up to 8).

2. Add wine and pomegranate juice, stir. Serve over ice in wine glasses, and include some of the fruit in each serving.

Adapted from Socarrat Restaurant, in New York City

Time: 10 minutes

Yield: 1 drink

2 ½ ounces gin

8 juniper berries, lightly crushed

2 dashes Angostura bitters

2 to 3 strips lemon peel (about ½ lemon)

4 ounces good-quality tonic water, chilled

1. Half-fill a large stemmed wine glass with ice. Add gin, juniper berries and bitters; stir.

2. Twist lemon peels over the glass to release the oils and drop them in. Add tonic water, stir and serve.

Time: 15 minutes

Yield: 6 drinks

1 cup chilled peach purée, preferably white (about 2 ripe peaches or purchased purée)

1 bottle (750 ml) rosé prosecco, preferably brut

12 fresh raspberries

1. Place 2 tablespoons peach purée in each of 6 champagne flutes. Slowly add 4 to 5 ounces prosecco, stopping as it bubbles up and continuing once it settles.

2. Drop 2 raspberries into each glass and serve.

Adapted from “The Ladies’ Village Improvement Society Cookbook”

Time: 10 Minutes

Yield: 2 drinks

2 ounces simple syrup

4 ounces white rum

2 ounces lemon juice

1 ounce lime juice

1 cup crushed ice or small ice cubes

Mint sprigs for garnish

1. Combine the simple syrup, rum and citrus juices in a cocktail shaker with ice; shake.

2. Strain into a blender with crushed ice. Blend until slushy, then pour into chilled goblets or glasses. Garnish with mint and serve.

Time: 5 minutes

Yield: 2 drinks

4 ounces blanco tequila or mezcal

3 ounces lime juice

3 ounces grapefruit juice

1 ounce grapefruit liqueur

4 ounces club soda or seltzer

Pinch chile powder or cayenne

Grapefruit wedges for garnish

1. Combine the tequila, citrus juices and grapefruit liqueur with ice in a cocktail shaker; shake well. Strain into tall glasses with ice and add soda.

2. Dust chile powder on top. Garnish with grapefruit and serve.

Time: 20 minutes plus chilling (optional)

Yield: 4 drinks

2 cups cubed ripe watermelon or honeydew, chilled

2 cups ice cubes

Juice of 1 lime

1 tablespoon simple syrup or agave syrup to taste (optional)

½ teaspoon salt, or to taste

Pinch ground white pepper

Basil sprigs for garnish

1. Purée the melon with ice in a blender. Stir in lime juice, syrup to taste, salt and pepper.

2. Transfer to a pitcher, add 2 cups water, stir and chill or pour into ice-filled glasses. Garnish with basil and serve.

Time: 15 minutes plus chilling

Yield: 6 drinks

4 cups brewed lemon verbena tea, chilled, or cold water

3 tablespoons simple syrup

Juice of 3 lemons (about ¾ cup)

1 cup diced strawberries, puréed

Lemon wheels and strawberry halves for garnish

1. Place tea or water in a pitcher or other container. Stir in simple syrup, lemon juice and strawberry purée. Chill at least 1 hour.

2. Stir well, pour into tall glasses filled with ice, garnish with lemon and strawberries and serve.

Time: 10 minutes

Yield: 1 drink

1 glass (4 to 6 ounces) fruity red wine (white or rosé can be substituted)

4 ounces sparkling water

Twist of lemon peel

3 ripe Bing cherries, pitted and halved

Pour wine into a large stemmed wine glass or goblet. Add sparkling water. Drop in lemon twist and cherries and serve.

Categories
Health

Ada Well being raises money from Samsung and Bayer for A.I. physician app

Berlin-based company Ada Health, which developed a doctor-style app that uses artificial intelligence to diagnose symptoms, was supported by the investment arms of South Korean company Samsung and German pharmaceutical giant Bayer.

Ada Health announced Thursday that it has initiated a $ 90 million round of funding with an undisclosed valuation that brings the total investment in the company to approximately $ 150 million.

Bayer led the round through its Leaps by Bayer investment arm, while Samsung invested through the Samsung Catalyst Fund, a US-based venture capital fund that Samsung Electronics uses to support companies worldwide. Young Sohn, former chief strategy officer and corporate president of Samsung Electronics, has joined the board of directors of Ada Health.

Ada Health was founded in 2011 by entrepreneurs Dr. Claire Novorol, Martin Hirsch and Daniel Nathrath and states that the app has been downloaded over 11 million times.

How it works

“The app works basically like a WhatsApp chat with your trusted family doctor, but around the clock,” CEO Nathrath told CNBC.

The patient starts typing in their symptoms and an AI chat bot asks a series of questions to help pinpoint the problem. After that, the app will show the patient the conditions that are most likely the cause and offer some suggestions on what to do next to fix the problem.

The iOS and Android apps provide general information on how to see a family doctor in the next three days. However, when patients interact with Ada Health through a healthcare system that uses the app, they can book an appointment directly and share the result of their preliminary exam with a real doctor, Nathrath said.

He said the company has signed contracts with multiple health systems, health insurers, and life science companies. Axa OneHealth, Novartis, Pfizer and SutterHealth are listed as partners on the Ada Health website.

While the app can be downloaded free of charge for patients, Ada Health charges its partners for access to the software.

The company said the new funds will be used to expand deeper into the US, which is already the largest market with 2 million users. Elsewhere, Ada Health has around 4 million users in the UK, Germany, Brazil and India with around 1 million each.

The funds will also be used to improve the company’s algorithms, expand the medical knowledge base, and go beyond 10 languages, Nathrath said.

He also wants to provide the Ada Health app with additional information beyond the symptom data provided by the patient. That could include lab data, genetic testing, and sensor data, Nathrath said.

“Smartwatches and other sensors have really made a big leap forward,” said Nathrath. “Nowadays you can measure your blood pressure, do an EKG, measure heart rate variability and blood oxygen levels.”

“Our goal is really to develop what is known as a personal operating system for health, in which you can not only carry out a symptom check, but also integrate all relevant sources of health information in such a way that Ada can ideally become this companion and notify you before the pound 100 problem is becoming a pound 100,000 problem a year. “

U-turn on tele health

Ada Health received less money than other “doctor” apps like Babylon and Kry.

Unlike Babylon and Kry, Ada Health does not allow patients to video call a family doctor.

Ada briefly ran a service called Doctor Chat, which allowed users to consult a registered GP through an on-demand chat portal. However, it was deactivated in March 2018 after having lived for about a year.

“We expected a lot more people to actually use this than they did,” said Nathrath, adding that people would prefer the automated chat experience to video calling with family doctors.

“If you look at telemedicine, you can’t scale it as well as an AI solution because you still have to hire a lot of doctors in different countries,” said Nathrath.

The investment in Ada Health comes just over two weeks after British health start-up Huma raised $ 130 million from the venture arms of Bayer, Samsung and Hitachi.

Other investors in the last round of Ada Health are Vitruvian Ventures, Inteligo Bank, F4 and Mutschler Ventures.

Categories
Health

What Satisfied Me to Begin Sporting Solar Safety

Alas, those of us in the upper decades of life knew little in our younger years about the risks of sun damage beyond the need to avoid a bad sunburn. Many youngsters like me swam, hiked, biked and played sports minimally clothed while the sun tanned or burned our skin. We sunbathed coated in baby oil in a misguided effort to acquire a rich tan. And many of us, myself included, failed to reach adulthood with sun-protective habits that could have prevented the skin damage now woefully apparent.

Given that the risk of ultraviolet light to healthy skin has since been widely publicized, I’m astonished at how many people today visit tanning salons or use tanning beds at home, damaging the wholesome cutaneous barrier nature gave us.

Happily, the new study suggests that more people now have a greater understanding and respect for the sun’s effects on skin and can look forward to a healthier future, said Dr. Sangeeta Marwaha, a dermatologist in Sacramento and co-author of the study. Among people who entered the study in 2018, the risk of developing skin cancer was two-thirds that of study entrants in 2008 who were followed for an equal number of years.

“There’s been an increase in sun-protective habits and a resulting decrease in the development of skin cancer,” Dr. Marwaha said in an interview. “Parents today are more likely to protect their children from undue sun exposure, and the use of sunscreen is now more mainstream.”

But there’s still a long way to go. Fostering a healthy respect for sun protection in young children is especially important because some experts estimate that up to 80 percent of a person’s lifetime sun exposure is acquired before age 18.

Repeated exposure to the sun’s ultraviolet radiation causes most of the skin changes — wrinkles, age spots and tiny broken blood vessels — generally considered a normal result of aging. Yes, aging plays a role, but these effects occur much earlier in life on sun-exposed skin. UV light damages the elastin fibers in skin, causing it to stretch, sag and wrinkle. It also damages surface blood vessels, rendering them more fragile and easily bruised.

And Zachary W. Lipsky, a biomedical engineer at Binghamton University, found that UV radiation weakens the bonds that help the cells in the top layer of skin stick together, damaging the skin’s structural integrity and leaving it more vulnerable to infection.

Categories
Health

UK instances of Covid variant recognized in India double in a single week

Hounslow, London, which has become one of the U.K.’s biggest hotspots for the variant of coronavirus first identified in India, on Thursday 27th May 2021.

Tejas Sandhu | MI News | NurPhoto | Getty Images

Cases of the Covid-19 variant first identified in India have more than doubled in England within one week, the country’s health authority said.

The number of cases of the strain had reached 6,959 by Wednesday, an increase of 3,535 cases from the previous week.

The B.1.617.2 variant, a highly contagious triple-mutant strain of the coronavirus, is likely to be more transmissible than the variant first identified in England last fall, Public Health England said Thursday.

Bolton, Bedford and Blackburn were the most affected areas in England, according to PHE, although it said there were small numbers of cases of the variant in most parts of the country.

Hospitalizations were also rising in some areas, PHE added, noting that most hospital admissions were in unvaccinated people.

Research published by PHE last week showed that two doses of Covid vaccines gives people high levels of protection against the B.1.617.2 strain.

Jenny Harries, CEO of the U.K. Health Security Agency, said in PHE’s weekly update that the public should continue to act with caution as Britain eases lockdown restrictions.

“We now know that getting both vaccine doses gives a high degree of protection against this variant and we urge everyone to have the vaccine,” she said.

“Make sure that you remain careful, work from home if you can, meet people outside where possible and remember ‘hands, face, space, fresh air’ at all times.”

The U.K. has begun to tentatively lift lockdown restrictions in recent months, with the government hoping to remove all measures by June 21.

However, Prime Minister Boris Johnson has warned that the country “may need to wait” for a complete return to normality, although he told the BBC on Thursday there was nothing “currently in the data” to suggest the June unlocking would be derailed.

Johnson announced earlier this month that the U.K. would accelerate second vaccine doses for the over-50s and clinically vulnerable in an effort to combat the spread of the B.1.617.2 strain.

More than 62.6 million vaccines had been given in the U.K. by May 26, with 73% of the adult population having received their first dose. Almost half of British adults have been fully vaccinated with both doses.

On May 22, 883 people were in hospital with Covid-19 in the U.K. — a huge drop from January’s peak of 39,249.

Categories
Health

Studying Dan Frank, E-book Editor and ‘Champion of the Unexampled’

I met him through Alan Lightman, who had emailed me to say he was coming to New York to give a talk, and did I want to have dinner with him and two guests — his daughter and a man named Dan.

I instantly felt this, just, radiance, a kind of humble warmth but also a very lively mind. He was such a lovely human being, so subtle and generous, an embodiment of what a great editor does: gets out of the way, taking with him the rubble that writers put in their own path.

He was very interested in the intersection of the novelist and the scholarly. He understood uniquely how all history is a kind of narrative superimposed on reality — an invention and interpretation. Science is a human-driven search for truth. Not in a social-constructivist way; there is an elemental truth. But the search can fold in on itself, because we only have the tools of human consciousness to work with. Whatever the prostheses — telescopes, microscopes — it’s still a human mind that does the processing and analysis, that filters everything through its life, its loves, the Dans it lost, everything.

The history of science is ultimately the history of human experience. Dan saw that there was something there to look at that defies the robotic model of objectivity. There is an animating question common to all the books he did: “What is all this? What is all this?”

Alan Lightman is a physicist and writer at M.I.T. He has published a dozen books with Dan Frank, starting in 1986 with “A Modern Day Yankee in a Connecticut Court. and Other Essays on Science.”

In March 30, 1983, I got a letter from an editor I had never heard of, saying that if there was ever a book I wanted to write, I should get in touch: “I have been reading your column, The Physical Element, for over a year, and I am particularly impressed with the ease and grace with which you elucidate complex ideas.”

That was powerful encouragement. Before the internet, Dan would always send me a letter before anything else; not a phone call, but a letter. I kept that letter and all the letters I ever got from him.

Categories
Health

UK approves Janssen single-dose Covid vaccine to be used

A box of Janssen COVID-19 vaccine doses from Johnson & Johnson is pictured in Grubbs Pharmacy on Capitol Hill on Monday April 12, 2021.

Tom Williams | CQ Appeal, Inc. | Getty Images

LONDON – The UK Medicines Agency approved Janssen’s single-dose Covid-19 vaccine for use on Friday.

The UK drug and health products regulator announced that doses are expected to be available in the UK later this year.

The UK Government’s Vaccine Taskforce has secured 20 million doses for launch across the UK. She initially received 30 million doses, but changed the order as the vaccination program continues on what the government calls “unprecedented” levels.

Earlier this year, the vaccine was found to be 67% effective in preventing infection and 85% in preventing severe cases of Covid and hospitalization. Janssen is a Johnson & Johnson pharmaceutical company.

UK Health Secretary Matt Hancock said Friday that approval of the Janssen vaccine would boost the country’s “hugely successful” vaccination program.

“As Janssen is a single-dose vaccine, it will play an important role in the months ahead as we redouble our efforts to encourage everyone to get their pokes and possibly start a booster program later this year.” he said in a statement.

The vaccine can be stored in refrigerators at 2 to 8 degrees Celsius, which makes it easier to store and transport than some alternative vaccines.

The vaccine is the fourth to be approved for use in the UK. Together with the alternatives Oxford-AstraZeneca, Pfizer-BioNTech and Moderna, it was approved by the MHRA.

The Vaccine Taskforce has secured early access to more than 500 million doses from eight vaccine candidates, including those developed by Novavax, GlaxoSmithKline and CureVac, and the four that the UK has already approved for use.

Safety and effectiveness

The government said it was in regular contact with the vaccine manufacturers to optimize supplies and prepare for a potential vaccination booster program later in 2021.

Janssen’s Covid-19 vaccine is currently involved in a government study to assess the safety and effectiveness of a third dose to boost immunity to the virus. The Oxford-AstraZeneca, Pfizer-BioNTech and Moderna vaccines each require two doses for patients to achieve optimal immunity.

The UK Joint Committee on Vaccination and Immunization will make updated recommendations on the use of the Janssen vaccine prior to its launch.

Janssen’s vaccine is already being used elsewhere, including the United States and the European Union.

Health officials have raised concerns about possible links between the vaccine and rare blood clots, but regulators have found that the vaccine’s benefits outweigh the risks.

Janssen is considering the possibility of a two-dose program for his vaccine, according to the UK Department of Health and Welfare.

The UK government has set a goal of offering all adults in the country a Covid vaccine by the end of July.

More than 62.6 million vaccines had been administered in the UK as of Wednesday, with 73% of the adult population receiving their first dose. Almost half of British adults were fully vaccinated with both doses.

Categories
Health

U.S. Masks Corporations Battle to Compete with China

In Congress, a bill with bipartisan support would allocate $500 million in annual spending over the next three years to support domestic manufacturers of vital medical equipment.

While industry executives commend these moves, they say that time is running out. The American Mask Manufacturer’s Association, a recently created trade group, said its 27 members had already laid off 50 percent of their work force. Without concerted action from Washington, most of those companies will go belly up within the next two months.

An immediate boost, they say, would be to rescind the C.D.C. guidelines, born during the pandemic, that force health workers to repeatedly reuse N95 masks, even though they are designed to be thrown away after contact with each patient. Many hospitals are still following the guidelines, even though 260 million masks are gathering dust in warehouses across the country.

“We’re not looking for infinite support from the government,” said Lloyd Armbrust, the association’s president and the founder and chief executive of Armbrust American, a mask-making company in Texas. “We need the government’s support right now because unfair pressure from China is going to kill this new industry before the legislators even get a chance to fix the problem.”

The association is planning to file an unfair trade complaint with the World Trade Organization, claiming that much of the protective gear imported from China is selling for less than the cost of production. The price for some Chinese-made surgical masks has recently dropped to as low as 1 cent, compared with about 10 to 15 cents for American masks that use domestically produced raw material.

“This is full-on economic warfare,” said Luis Arguello Jr., vice president of DemeTech, a medical-suture company in Florida that earlier this month laid off 1,500 workers who made surgical masks. He said that in the coming weeks, 500 other workers who make N95 masks would also likely be let go.

“China is on the mission to make sure no one in the industry survives, and so far they’re winning,” Mr. Arguello said.

Categories
Health

Doximity recordsdata for IPO and says docs will get allocation

Uber offered it to the drivers. Airbnb did it for hosts. Now Doximity is making it available to doctors, but in a much bigger way.

In its IPO prospectus on Friday, health tech company Doximity – often referred to as LinkedIn for Doctors – announced that it will allocate up to 15% of the shares in the Doctors offering through a “reserved share program”.

This means eligible doctors can get shares at the same price as the select group of institutional investors who so often benefit from the IPO pop because they get an early allocation and don’t have to wait for trading to start. Doximity hasn’t yet said how many shares it plans to issue or at what price. In order to qualify for the program, members must meet certain activity thresholds.

“We strive to be the world’s largest physician-owned technology company, and our reserved stock IPO program is designed to both thank our members and help the process,” wrote co-founders Jeff Tangney, Nate Gross and Shari Buck in the Founder’s Letter section of the prospectus.

Airbnb, which went public in December, has reserved up to 7% of the shares in its IPO for hosts on the platform. After the stock fell 112% on its debut, hosts who bought the maximum number of shares posted a paper profit of over $ 15,000 on day one.

There is no guarantee that the stock will rally like this. When Uber went public in 2019, the hailship company made up to 3% of its offering available to drivers. IPO buyers are only up 14% while the Nasdaq Composite is up 74% over that stretch. Meanwhile, trading app Robinhood announced last week that it was launching a product called IPO Access to give retail investors more opportunities to get into deals at asking price.

Founded in 2011, Doximity is largely under the radar, despite being based in San Francisco. The company has not borrowed since 2014, only raised around $ 80 million in venture finance in its decade as a private company, and spent very little on marketing. The company is also profitable: net income rose 69% to $ 50.2 million last fiscal year.

Doximity has grown rapidly as doctors have become the standard location across the country to connect with each other and stay up to date on new research. It was also a very valuable tool for medical recruiters. The service is now used by 1.8 million medical professionals in all top 20 hospitals and health systems, according to the prospectus.

Revenue rose 78% last year to $ 206.9 million. Sales and marketing accounted for 30% of total sales. Most of that is “staff expenses, sales commissions, travel expenses, and other event expenses,” with a little bit spent on Google and Facebook ads. Only $ 2.6 million went into advertising last year.

While Doximity doesn’t do a lot for advertising, it generates a healthy amount of revenue from medical and pharmaceutical companies that use the app to reach out to doctors. All top 20 drug manufacturers use the service to educate medical professionals about their products. The company said its subscription paid marketing solutions product represented over 80% of sales in the past fiscal year.

Most of the remaining revenue comes from hiring solutions used by healthcare systems and medical recruitment firms to connect with Doximity’s doctors.

Doximity said it has more than 600 subscription customers, including 200 who spent $ 100,000 in fiscal 2021. Of those, 29 spent at least $ 1 million. Subscriptions made up 93% of total sales.

Doximity also launched a telemedicine product last year when Covid-19 forced patients to stay at home and communicate with their doctors remotely. The company only started charging for the telehealth service in early January.

“We have seen rapid adoption of our telehealth solutions by our healthcare customers as Doximity members who have used our productivity tools in the past have used organically,” the company said.

Doximity said it is competing with LinkedIn for members. It competes against recruiting companies in hiring and recruiting, while in the telemedicine market it faces competition from Teladoc and American Well and the universal video chat app Zoom.

CLOCK: Robinhood to allow users to get involved in IPOs

Categories
Health

C.D.C. Says Vaccinated Camps Can Cease Masking and Distancing

Federal health officials are encouraging young people aged 12 and over who are heading to camp this summer to get vaccinated against the coronavirus as soon as possible, saying on Friday that camps where all staff and campers are vaccinated can drop many Covid restrictions, including masks, and return to full capacity. Unvaccinated children can also go without masks most of the time when they are outside because the risk of transmission outdoors is low.

“For camps where everyone is fully vaccinated prior to the start of camp, it is safe to return to full capacity, without masking and without physical distancing,” the new guidance says.

In camps where not everyone is fully vaccinated, mask recommendations for all have been relaxed for most outdoor activities, unless the setting is crowded and involves sustained close contact. But other prevention strategies should be maintained, including physical distancing, grouping youngsters in cohorts or pods that don’t mix with one another; encouraging frequent hand washing; avoiding crowded settings and poorly ventilated indoor areas.

The guidance, issued by the Centers for Disease Control and Prevention, says that if campers prefer to wear masks despite being fully vaccinated, camps should be supportive of their choice. Staff members and campers with compromised immune systems are urged to talk to their providers, and continue practicing precautions, like wearing masks.

Individuals are considered fully vaccinated by the C.D.C. two weeks after receiving the one-shot Johnson & Johnson vaccine or the second dose of either the Pfizer-BioNTech or Moderna vaccines.

“We’re going to start to see more and more adolescents fully vaccinated by mid summer, so it is possible that camps could provide a camp experience for children who are fully vaccinated, and you could get back to the camp experience that was pre-pandemic: no masking, no distancing, and all the activities you would normally do,” said Erin Sauber-Schatz, who leads the C.D.C. task force for community interventions and critical populations.

She noted that 2.5 million children aged 12 to 15 have received the first dose of a Pfizer vaccine in the last 18 days alone.

Individual camps will have the flexibility to determine both how they go about verifying the vaccination status of campers and how they run programs where not everyone is fully vaccinated, she said. They could mix vaccinated and unvaccinated campers or group them in separate cohorts with different rules, she said, or decide that in order “to keep non-vaccinated campers as safe as possible, they may have standard rules across the camp regardless of vaccination status.”

The guidance to campers comes after the agency’s recent recommendation that fully vaccinated people can choose to go maskless in most situations.

Though there is still no vaccine for children under the age of 12, the Food and Drug Administration authorized the use of the Pfizer vaccine in children aged 12 to 15 earlier this month. Younger children will probably be eligible for vaccination in the fall.

Tom Rosenberg, president and chief executive of the American Camp Association, a nonprofit that accredits camps, said the new guidance was issued just in time, as many camps in the southern United States start as early as next week.

But, he said, “The reality is that the majority of camps are for kids six years old to 17, so a good portion of the kids attending camp, by virtue of their age alone, will not be vaccinated. So camps are preparing to manage another Covid summer with a layered mitigation strategy, like last year.”

Federal health officials urged camps where campers are vaccinated to continue with other precautions, including making sure there is good ventilation in indoor spaces by keeping windows open, using fans and air filters; practicing good hand hygiene and respiratory etiquette; and cleaning and disinfecting high-touch areas frequently.

Categories
Health

WHO says Covid origin investigation is being ‘poisoned by politics’

Executive Director of the World Health Organization’s (WHO) emergencies program Mike Ryan speaks at a news conference on the novel coronavirus (2019-nCoV) in Geneva, Switzerland.

Denis Balibouse | Reuters

A top World Health Organization official said Friday that investigations into the origins of Covid-19 are being “poisoned by politics.”

U.S. President Joe Biden announced Wednesday that he’s ordered intelligence agencies to conduct “a report on their most up-to-date analysis of the origins of Covid-19, including whether it emerged from human contact with an infected animal or from a laboratory accident.”

The WHO has come under increasing pressure in recent days from U.S. and European officials to take another look at whether the coronavirus could have escaped from a lab in Wuhan, China, after a previously undisclosed U.S. intelligence report came to light, revealing that three researchers sought hospital care after falling ill with Covid-like symptoms in November 2019.

Dr. Mike Ryan, executive director of WHO’s Health Emergencies Program, asked if countries could separate the politics from the science.

“Putting WHO in a position like it has been put in is very unfair to the science we’re trying to carry out, and it puts us as an organization, frankly, in an impossible position to deliver the answers that the world wants,” Ryan said at a news briefing.

The WHO has been repeatedly accused of allowing the Chinese government to avoid a thorough investigation into the origins of Covid-19, which was first discovered in Wuhan in late 2019. At a Senate hearing earlier this week Sen. John Kennedy, R-La., pressed White House chief medical advisor Dr. Anthony Fauci on the WHO’s close ties to China.

“Can we agree that if you took (Chinese) President Xi Jinping and turned him upside down and shook him, the World Health Organization would fall out of his pocket?” Fauci responded by saying that he has no way of knowing China’s influence on the agency.

The hypothesis that Covid-19 came from a Wuhan virology lab was initially dismissed as a right-wing conspiracy theory, but it’s been gaining traction in recent weeks.

The majority of the intelligence community believes that it is equally plausible that the virus originated in a lab and in an animal. Federal health officials continue to maintain their position that it is more likely that the virus has zoonotic origins. The CDC’s website still states “we know that it originally came from an animal, likely a bat.”